# Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace Tablets

> **NCT02718846** · PHASE4 · COMPLETED · sponsor: **Alvogen Korea** · enrollment: 220 (actual)

## Conditions studied

- Meniere's Disease

## Interventions

- **DRUG:** Meniace
- **DRUG:** Isobide

## Key facts

- **NCT ID:** NCT02718846
- **Lead sponsor:** Alvogen Korea
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2016-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02718846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02718846, "Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace Tablets". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02718846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*